Get the Stockscreener App
1.04
4.59%
-0.05
After Hours:
1.05
0.01
+0.96%
Cardiol Therapeutics Inc stock is traded at $1.04, with a volume of 601.13K.
It is down -4.59% in the last 24 hours and down -4.59% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.09
Open:
$1.09
24h Volume:
601.13K
Relative Volume:
0.69
Market Cap:
$89.38M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-3.1316
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
-2.80%
1M Performance:
-4.59%
6M Performance:
+16.07%
1Y Performance:
-41.57%
1-Day Range:
$1.03
$1.09
1-Week Range:
$1.03
$1.11
52-Week Range:
$0.7709
$2.24
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.04 | 91.27M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Custom watchlist performance reports with Cardiol Therapeutics Inc.Portfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
What MACD signals say about Cardiol Therapeutics Inc.2025 Year in Review & Expert Verified Movement Alerts - newser.com
What does recent volatility data suggest for Cardiol Therapeutics Inc.Rate Cut & Expert Curated Trade Setup Alerts - newser.com
Can Cardiol Therapeutics Inc. hit a new high this monthJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Using fundamentals and technicals on Cardiol Therapeutics Inc.Volume Spike & Reliable Entry Point Alerts - newser.com
What data driven models say about Cardiol Therapeutics Inc.’s future2025 Analyst Calls & Entry Point Strategy Guides - newser.com
Can Cardiol Therapeutics Inc. (CT9) stock deliver strong annual returnsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Cardiol Therapeutics Inc Stock Analysis and ForecastSwing Trading Watchlist & Small Investment Big Gains - earlytimes.in
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Backtesting results for Cardiol Therapeutics Inc. trading strategiesJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Should you wait for a breakout in Cardiol Therapeutics Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
What drives Cardiol Therapeutics Inc stock priceMarket Sentiment Shifts & Low Entry Capital Stocks - earlytimes.in
(CRDL) Strategic Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Published on: 2025-10-06 07:18:06 - newser.com
Trend Tracker for (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Predicting Cardiol Therapeutics Inc. trend using moving averages2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
What technical signals suggest for Cardiol Therapeutics Inc. stockTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Applying big data sentiment scoring on Cardiol Therapeutics Inc.2025 Risk Factors & Intraday High Probability Alerts - newser.com
Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Up 5.6% – Time to Buy? - Defense World
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Is Cardiol Therapeutics Inc. (CT9) stock overpriced at current multiples2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Can you recover from losses in Cardiol Therapeutics Inc.Market Growth Report & Reliable Price Action Trade Plans - newser.com
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 3.3% – Should You Sell? - Defense World
How strong dollar benefits Cardiol Therapeutics Inc. (CT9) stockJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 3.3%Should You Sell? - MarketBeat
How forex fluctuations impact Cardiol Therapeutics Inc. (CT9) stockEarnings Miss & Weekly Breakout Stock Alerts - newser.com
(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc CT9 Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Maximum Profit Growth - earlytimes.in
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):